PMC:7594251 / 91547-91843
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T104 | 220-223 | Disease | denotes | CSP | http://purl.obolibrary.org/obo/MONDO_0005078 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T646 | 21-24 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T647 | 46-51 | http://purl.obolibrary.org/obo/UBERON_0007688 | denotes | field |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T526 | 132-136 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T591 | 0-154 | Sentence | denotes | Substantial progress has been made in the NMR field over the past 5–10 years, and various methods were established to determine the drug-target complexes. |
| T592 | 155-296 | Sentence | denotes | Most of them utilize either NOE or chemical shift perturbations (CSP) although in silico models/programs, using NMR-derivate data also exist. |